Candice is a family nurse practitioner with over a decade of experience in health care. At Guardant Health, she leverages her clinical and public health expertise to support the use of genomic testing in cancer care. She also co-leads the Guardant Health Advanced Practitioner Education Committee, helping to strengthen education and engagement among oncology advanced practitioners.

Cristin O'Neal MSN, ANP-c is an advanced practitioner with 18 years of oncology experience, including 7 years as a nurse practitioner in oncology. She is currently part of the Medical Affairs team at Guardant Health, where she provides molecular education to oncology practices nationwide. Cristin also co-leads the Guardant Health Advanced Practitioner (AP) Education Committee, which supports external training and development for APs in oncology.

Patricia Crabtrey began her nursing career as a Registered Nurse in 1991, she brings a diverse clinical background that includes experience in Emergency Room (ER), Intensive Care Unit (ICU), and Interventional Radiology. Her commitment to patient care and clinical excellence led her to join MD Anderson Cancer Center in 2008, where she began working in the Radiation Oncology department.Initially serving as an RN at one of MD Anderson’s Houston Area Locations, she departed in 2012 to pursue advanced education. In 2013, she earned her Master’s degree from the University of Texas Health Science Center in Houston and returned to MD Anderson in 2014, joining the Genitourinary Radiation Oncology Service.In late 2023, she transitioned to MD Anderson’s Sugar Land location to collaborate with Dr. Shalin Shah, supporting the development and growth of the Benign Program.

Christa Braun-Inglis was the first oncology nurse practitioner in the state of Hawaii. Dr. Braun-Inglis has been instrumental on the local and national level in expanding the role of advanced practice providers (APPs) in clinical trials. She has also advocated for cancer clinical trials in the community setting and diverse patient enrollment in clinical trials. With over 25 years of oncology nursing experience, she holds a dual role as both a nurse practitioner and an assistant researcher at the University of Hawaii Cancer Center in Honolulu, Hawaii. She is also a clinical faculty member at the University of Hawaii School of Nursing. Through her efforts, the National Cancer Institute (NCI) revised their policies in 2021, empowering APPs to fully exercise their credentials and enroll patients in supportive care trials. In 2023, she received the National Cancer Institute’s Director’s Award. In addition, she is also the current Chair of the Research and Quality Improvement committee of APSHO.

Ms. Lisa A. Kottschade is an Associate Professor of Oncology and a Nurse Practitioner in the Melanoma and Cutaneous Oncology and Immunotherapy Toxicity Clinics at Mayo Clinic. Recently she was named the Chair of Research Committee for the Office of NP/PA in Rochester. She is the current President of APSHO as well as leads the Alliance Oncology Nursing Committee. Her clinical and research interests include those in the field of melanoma including its treatment and management of side effects from therapy with a special focus on those related to Immune Checkpoint Inhibitors.

Mee-young Lee is a nurse practitioner with over 25 years of oncology experience. She earned her MSN from the University of Pennsylvania in 2006 and has held clinical roles at Beth Israel Deaconess Medical Center, Northwell Health, and St. Francis Heart Hospital. She currently practices at Dana-Farber Cancer Institute, specializing in thoracic oncology. Mee-young is also an active member of the Research and Quality Improvement Committee of the Advanced Practitioner Society for Hematology and Oncology (APSHO).

Ashley received a Master of Science in nursing degree from University of Hawaii at Manoa. She has been a nurse practitioner in medical oncology and hematology for over 10 years. Ashley is a member of APSHO’s Research and Quality Initiative Task Force. She currently serves as co-chair for the CCDR/Symptom management disease site working group and member of the thoracic and hematology disease site working groups at the University of Hawaii Cancer Center. She has served as site PI for several CCDR/Symptom management clinical trials as well as serving as a non-physician investigator on cooperative group and industry therapeutic clinical trials. She also maintains an active role precepting nurse practitioner students.

Emery Bergey, MBA, MSN, APRN, AGCNS-BC, OCN, is a clinical nurse specialist and advanced practice provider in the department of Radiation Oncology at Moffitt Cancer Center in Tampa, Florida. She holds multiple advanced degrees and certifications, including a Master of Science in Nursing Education, an MBA, and a post-master’s certificate in advanced practice nursing. Emery has extensive experience in oncology nursing, Lean Six Sigma, and trauma-informed care. She has worked as a lead RN case manager at the University of Florida Proton Therapy Institute and is a National Innovation and Entrepreneurship Fellow. Emery is dedicated to advancing holistic care for adolescent and young adult oncology patients and advocating for oncofertility care.

Dr. Sandra Cuellar is a Clinical Associate Professor in the Department of Pharmacy Practice at the University of Illinois at Chicago (UIC) College of Pharmacy and a clinical oncology pharmacist at UI Health. She received her PharmD degree from the University of Illinois at Chicago College of Pharmacy and then completed a Pharmacy Practice Residency at University of Kentucky Chandler Medical Center. Following her residency, she completed a specialty oncology residency at MD Anderson Cancer Center in Houston. Dr. Cuellar is the director of the oncology residency program and chair of the IRB at UI Health. Dr. Cuellar is an editor at large for the Journal of Hematology Oncology Pharmacy and an invited lecturer to national organizations, including HOPA, ASHP, ACCP, ACCC, and AMCP. In addition, Dr. Cuellar was recently appointed to be a member of the ASHP Commission on Credentialing and past chair of the industry relation council for the Hematology Oncology Pharmacy Association. 

Amber Koehler is a PA who specializes in care of CLL patients at Mayo Clinic in Rochester, MN. She is an Assistant Professor of Medicine, a Senior Fellow in the Mayo Clinic Academy of Educational Excellence, and a member of both the Mayo Clinic Committee for Employee Well-Being and the NP PA Executive team, where she serves as Chair of the NP PA Recognition & Communication Subcommittee. She is also currently serving as Chair of the APSHO Education Committee. Outside of work, she loves spending time in the mountains and impromptu kitchen dance parties with her son, Nathaniel.

Srigowri Kota, MSN, BA, APN, AGNP-C, AOCNP, is a nurse practitioner in the GU Medical Oncology Group at Rutgers Cancer Institute. In her role, she manages patients on chemotherapy, oral oncolytics, bio/immunotherapy, antibody-drug conjugates (ADCs), targeted therapies, and clinical trials, calling on her in-depth oncology-specific knowledge base for clinical decision capability. Ms. Kota initially joined Rutgers Cancer Institute as a nurse clinician in adult infusion and then transferred to the Stacy Goldstein Breast Cancer Center. She moved into her current role after graduating from the nurse practitioner program at Drexel University. Her nursing experience includes medical oncology in community, inpatient, and outpatient settings. Ms. Kota has been an author on several publications and is frequently engaged as an expert speaker in the identification and management of toxicities and adverse events from ADC therapy in oncology.

Dr. Clemmons received her Doctor of Pharmacy degree from the University of Michigan College of Pharmacy, completed a University of Georgia College of Pharmacy Teaching Certificate during her PGY1 year at MCG Health/UGA, and PGY2 Hematology/Oncology Pharmacy residency at the University of North Carolina (UNC Hospitals and Clinics), Chapel Hill NC. She is currently a Clinical Professor at the University of Georgia College of Pharmacy and clinical pharmacy specialist for the adult bone marrow transplantation (BMT)/malignant hematology team at Wellstar-MCG Health. She is a highly active member of the Hematology Oncology Pharmacy Association (HOPA) and the American Society for Transplantation and Cellular Therapy (ASTCT) Pharmacy Special Interest Group (SIG), as well as a member of ASHP, GSHP, and the Georgia Cancer Center. Dr. Clemmons has received the ASTCT Pharmacy SIG New Practitioner of the Year Award (2014), Teacher of the Year Award at the UGA College of Pharmacy (2016), the HOPA New Practitioner Award (2017) and received HOPA fellow status (FHOPA) in 2022. Dr. Clemmons serves as the Residency Program Director for the UGA/Wellstar MCG Health Medical Center PGY2 Oncology Pharmacy program.